S&CO Inc’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Sell
4,820
-398
-8% -$31.4K 0.02% 183
2025
Q4
$427K Sell
5,218
-53
-1% -$4.13K 0.03% 175
2025
Q3
$395K Sell
5,271
-52
-1% -$3.88K 0.02% 182
2025
Q2
$394K Hold
5,323
0.03% 181
2025
Q1
$429K Sell
5,323
-1
-0% -$86 0.03% 177
2024
Q4
$416K Hold
5,324
0.03% 169
2024
Q3
$499K Hold
5,324
0.03% 174
2024
Q2
$414K Sell
5,324
-623
-10% -$50.8K 0.03% 181
2024
Q1
$540K Sell
5,947
-7,281
-55% -$606K 0.04% 170
2023
Q4
$1.02M Sell
13,228
-2,852
-18% -$200K 0.08% 128
2023
Q3
$1.09M Sell
16,080
-457
-3% -$33.3K 0.09% 113
2023
Q2
$1.34M Sell
16,537
-86
-0.5% -$6.86K 0.11% 107
2023
Q1
$1.36M Buy
+16,623
New +$1.19M 0.12% 103

Other funds holding GEHC

S&CO Inc's GEHC Position: Q1 2026 in Review

S&CO Inc reduced its GE HealthCare (GEHC) stake by 7.6% in Q1 2026, selling an estimated $31.4K and leaving 4,820 shares worth $343K. The position accounts for 0.02% of the portfolio, ranked #183.

S&CO Inc first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.36M in Q1 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • S&CO Inc held 4,820 shares of GE HealthCare worth $343K as of Q1 2026.
  • S&CO Inc sold 398 GE HealthCare shares in Q1 2026, an estimated $31.4K.
  • GE HealthCare made up 0.02% of S&CO Inc's portfolio in Q1 2026, its #183 holding.
  • S&CO Inc first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • S&CO Inc's GE HealthCare position peaked at $1.36M in Q1 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.